An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients
NCT02322580 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56
Last updated 2016-12-02
Summary
The purpose of this study is to investigate the association between trough serum levels of etanercept, antibodies towards etanercept and its effectiveness in psoriasis patients.
Conditions
Interventions
- DRUG
-
etanercept
Sponsors & Collaborators
- collaborator INDUSTRY
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2016-09-30
- Completion
- 2016-11-30
More Related Trials
-
Enbrel® in Psoriatic Arthritis
NCT00111124 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
NCT00293722 ·Status: COMPLETED
-
Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis
NCT00421915 ·Status: COMPLETED ·Phase: PHASE3
-
Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis
NCT02376790 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists
NCT00293709 ·Status: COMPLETED
-
Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
NCT00420238 ·Status: COMPLETED ·Phase: PHASE4
-
Etanercept for Treatment of Hidradenitis
NCT00107991 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis
NCT00273858 ·Status: TERMINATED
-
An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical Trial
NCT01793285 ·Status: COMPLETED
-
Defining Remission With Etanercept in AS in Real Life Clinical Practice
NCT02202850 ·Status: COMPLETED
-
REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)
NCT00127842 ·Status: COMPLETED ·Phase: PHASE4
-
Etanercept (Enbrel) in Undifferentiated Spondyloarthritis
NCT01289730 ·Status: UNKNOWN ·Phase: PHASE2
-
Study Investigating Enbrel Treatment for Ankylosing Spondylitis
NCT00195416 ·Status: COMPLETED
-
Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
NCT04507763 ·Status: COMPLETED
-
Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria
NCT01877239 ·Status: COMPLETED
-
Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
NCT01421303 ·Status: COMPLETED
-
Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice
NCT02202837 ·Status: COMPLETED
-
Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis
NCT00418548 ·Status: COMPLETED ·Phase: PHASE3
-
Etanercept (Enbrel) in Ankylosing Spondylitis
NCT01289743 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept
NCT01901185 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis
NCT00544557 ·Status: COMPLETED
-
Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes
NCT01258738 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
NCT00227227 ·Status: COMPLETED
-
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
NCT01313208 ·Status: COMPLETED ·Phase: PHASE4
-
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
NCT01875991 ·Status: COMPLETED ·Phase: PHASE4